https://www.pagepressjournals.org/index.php/gc/issue/feed Geriatric Care 2020-07-07T21:00:17+00:00 Paola Granata paola.granata@pagepress.org Open Journal Systems <p><strong>Geriatric Care</strong> is the official journal of <a href="http://www.sigot.org/" target="_blank" rel="noopener">SIGOT</a> (<em>Società Italiana di Geriatria Ospedale e Territorio</em>), it is a recently-launched Open Access journal that seeks to publish high quality, peer-reviewed manuscripts dealing with the Geriatric Care in the different settings including the hospitals, residential services, nursing homes and home-care services for the elderly. The aim of the journal is to stimulate debate and dissemination of knowledge in the geriatric field in order to ameliorate efficacy, effectiveness and efficiency of interventions to improve health outcomes of the elderly people. <strong>Geriatric Care</strong> publishes contributions of epidemiology, pathophysiology and clinical assessment, management and treatments of the diseases of the older people, as well as health education and environmental health, hospital-residential-homecare management of the elderly including ethics, social and communication sciences, e-health and health technology assessment. Contributions on innovative topics of biological and genetics research, gender and disparity issues, as well as high-technology supports, i.e. domotics and robotics for the elderly, are welcome. <strong>Geriatric Care</strong> publishes <em>Original Articles</em>, <em>Review Articles</em>, <em>Brief Reports</em>, <em>Case Reports</em>, <em>Statement Reports</em> and <em>Editorials</em>.</p> <p>This journal does not apply charge for publication to Authors as it is supported by institutional funds.</p> https://www.pagepressjournals.org/index.php/gc/article/view/9121 COVID-19 and cardiovascular disease in elderly patients: a challenge in the challenge 2020-07-07T21:00:14+00:00 Raffaele Costa costa.raffaele@libero.it Alberto Castagna albertocastagna@tiscali.it Carlo Torchia measure@tiscali.it Carmen Ruberto carmenruberto@libero.it Giovanni Ruotolo giovanni.ruotolo1@virgilio.it <p>On 11 March 2020, the World Health Organization declared a pandemic state, in relation to the spread of the severe acute respiratory syndrome-coronavirus disease- 2, responsible for the coronavirus disease- 2019 (COVID-19). The pandemical blast of COVID-19 uncovered well known weakness of financial chain and put our economic organizations facing off dramatic consequences if new strategies will not be developed to adapt health-care on detailed sub-groups of patients. Frail individual aged &gt;65 years affected by cardiovascular disease are an aged population that showed a particular attitude to contract infection and a higher mortality rate compared to general population. In this brief article, we will focus on the management of issues related to cardiovascular patients facing coronavirus infection, in particular in the most fragile groups of the population such as the elderly, increasingly numerous and affected by multimorbidity. Protecting aged populations will be a central question, probably primary in everyone’s interest.</p> 2020-06-15T00:00:00+00:00 ##submission.copyrightStatement## https://www.pagepressjournals.org/index.php/gc/article/view/9056 Kinesiophobia dilemma for older adults: a systematic review 2020-07-07T21:00:15+00:00 Alebtekin Ahangari alepahangari@yahoo.com Mohammad Abdolrahmani m.abd.ac@gmail.com <p>Kinesiophobia is one of the pain complications which eventually might cause disability. Several studies showed correlation between age-related problems with kinsiophobia. The objective was to investigate clinical trials about managing kinesiophobia among older adults aged +65 years until March 2020. PubMed, CINAHL, Google Scholar, and PsycINFO databases were electronically searched until March 2020. All studies about kinesiophobia, with clinical trials, and randomized trials study design among older adults aged +65 years were included in the review. Two set of searching terms including ‘<em>kinesiophobia AND intervention</em>’ and ‘<em>fear of movement AND intervention</em>’ were used. From a total of 2669 articles, after excluding for different reasons, only three articles with total of 87 participants, mean age 68.5, all from Turkey related to the objectives of this study remained. Two of them were evaluated using two different physiotherapy approaches to manage neck pain and low back pain and one of them was regarding falls. Kinesiophobia was used as measure for the effectiveness of treatments. Older adults with routine and properly designed exercise and activity are healthier, with a lower probability for disability and therefore higher quality of life and longer healthy life. But to reach those goals, agerelated diseases and barriers should be investigated.</p> 2020-06-15T00:00:00+00:00 ##submission.copyrightStatement## https://www.pagepressjournals.org/index.php/gc/article/view/8934 A case of purple urine bag syndrome in an elderly patient 2020-07-07T21:00:17+00:00 Rosa Paola Cerra rosapaolacerra@gmail.com Alberto Castagna albertocastagna@tiscali.it Carlo Torchia carlotorchia@hotmail.it Raffaele Costa costa.raffaele@libero.it Luigi Scalise measure@tiscali.it Edoardo Suraci edoardosuraci88@gmail.com Giovanni Ruotolo giovanniruotolo@virgilio.it <p>Purple urine bag syndrome is a rare condition that occurs predominantly in the elderly, immobilized and <em>bearer</em> of chronic bladder <em>catheter</em>. It is a phenomenon usually associated with urinary tract infection, particularly in the presence of high bacterial load. The presence of alkaline urine, constipation, high-protein diet and dehydration are predisposing factors. In most cases it is an asymptomatic condition. We described the case of an elderly patient admitted to the geriatric Department in which purple urine was found in the urine collection bag. The culture of urine showed the presence of infection with <em>Klebsiella pneumoniae</em>. Targeted antibiotic treatment and proper hydration determined the resolution of the phenomenon and the resolution of the infection. Although it is an alarming phenomenon due to the particularity of the color of the urine, it is a treatable and solvable condition with an adequate specific antibiotic treatment. Prevention measures are equally effective and consist in eliminating the risk factors for this condition.</p> 2020-06-15T00:00:00+00:00 ##submission.copyrightStatement## https://www.pagepressjournals.org/index.php/gc/article/view/9093 Interferon-beta: treatment option against COVID-19 2020-07-07T21:00:12+00:00 Faiz Ul haq faizulhaq553@gmail.com Muhammad Usman Khan usman.a.khan415@gmail.com Ayesha Muazzam ayesha.faizan2011@gmail.com Hajrah Farooq hajrahfarooq11@gmail.com Javeria Iqbal javeriaiqbal98@gmail.com Muhammad Imran imranmuhammad686@gmail.com Rabia Bashir drrabiabashir@gmail.com Sania Ahmad saniahmed357@gmail.com Sara Arif dr.saraarif@gmail.com <p>In December 2019, an increasing number of cases of novel coronavirus (2019-nCoV) that were linked to seafood wholesale market have identified in Wuhan, China. Taxonomist declared 2019-nCoV as severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2) and the disease termed as COVID-19. Importantly, there is no approved drugs or vaccine against SARS-CoV-2. Current review is related to address treatment option for COVID-19. Interferon-β have shown significant activity against previous outbreak of SARS-CoV and MERS-CoV. Faced with an ongoing pandemic of SARS-CoV-2 and lack of effective treatment options, identifying compounds with antiviral activity has become a high priority. Efficacy of these treatments is still unclear. Therefore, final analysis is important to develop better treatment strategies for ongoing pandemic.</p> 2020-07-06T14:40:03+00:00 ##submission.copyrightStatement##